Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Geinitz

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Plos One|March 2, 2023
Radiation-induced alterations in multi-layered, in-vitro skin models detected by optical coherence tomography and histological methodsLuisa Bromberger, Bettina Heise, Karoline Felbermayer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2018
Optimal time-point for <sup>68</sup>Ga-PSMA-11 PET/CT imaging in assessment of prostate cancer: feasibility of sterile cold-kit tracer preparation?Mohsen Beheshti, Zeinab Paymani, Joana Brilhante, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2026
Radiotherapy at the limits of age: evolving fractionation strategies, symptom palliation, and survival in nonagenariansGeorg Gruber, Christina-Marie Kasassov, Annette Aigner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 19, 2010
Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancerHans Geinitz, Reinhard Thamm, Christian Scholz, et al.
World Journal of Surgery|November 27, 2008
Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevanceDietrich Doll, Ralf Gertler, Matthias Maak, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 17, 2019
Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working groupDiana Steinmann, Dirk Vordermark, Wiebke Gerstenberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2011
Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWIMatthias Eiber, Konstantin Holzapfel, Carl Ganter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancerMichael Souvatzoglou, Bernd J Krause, Anja Pürschel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 30, 2006
PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancerHinrich A Wieder, Hans Geinitz, Robert Rosenberg, et al.
Journal of Clinical Medicine|August 27, 2020
Additional Value of 2-[<sup>18</sup>F]FDG PET/CT Comparing to MRI in Treatment Approach of Anal Cancer PatientsReyhaneh Manafi-Farid, Alexander Kupferthaler, Helwig Wundsam, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Plos One|March 2, 2023
Radiation-induced alterations in multi-layered, in-vitro skin models detected by optical coherence tomography and histological methodsLuisa Bromberger, Bettina Heise, Karoline Felbermayer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2018
Optimal time-point for <sup>68</sup>Ga-PSMA-11 PET/CT imaging in assessment of prostate cancer: feasibility of sterile cold-kit tracer preparation?Mohsen Beheshti, Zeinab Paymani, Joana Brilhante, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2026
Radiotherapy at the limits of age: evolving fractionation strategies, symptom palliation, and survival in nonagenariansGeorg Gruber, Christina-Marie Kasassov, Annette Aigner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 19, 2010
Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancerHans Geinitz, Reinhard Thamm, Christian Scholz, et al.
World Journal of Surgery|November 27, 2008
Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevanceDietrich Doll, Ralf Gertler, Matthias Maak, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 17, 2019
Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working groupDiana Steinmann, Dirk Vordermark, Wiebke Gerstenberg, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2011
Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWIMatthias Eiber, Konstantin Holzapfel, Carl Ganter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancerMichael Souvatzoglou, Bernd J Krause, Anja Pürschel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 30, 2006
PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancerHinrich A Wieder, Hans Geinitz, Robert Rosenberg, et al.
Journal of Clinical Medicine|August 27, 2020
Additional Value of 2-[<sup>18</sup>F]FDG PET/CT Comparing to MRI in Treatment Approach of Anal Cancer PatientsReyhaneh Manafi-Farid, Alexander Kupferthaler, Helwig Wundsam, et al.
Pageof 9